Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors

By Tsuboi Masahiro   Chevalier Thierry  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 161-170

Humana Press, Inc

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Signaling in Nonsmall Cell Lung Cancer

By Ganti Apar Kishor  

Cancer Investigation, Vol. 28, Iss. 5, 2010-05 ,pp. : 515-525

Informa Healthcare

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibitors: A New Prospective in the Treatment of Lung Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 2, 2004-03 ,pp. : 139-148

Bentham Science Publishers

Access to resources Recommend Favorite

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

By Clarke Jennifer   Pao William   Wu Nian   Miller Vincent   Lassman Andrew  

Journal of Neuro-Oncology, Vol. 99, Iss. 2, 2010-09 ,pp. : 283-286

Springer Publishing Company

Access to resources Recommend Favorite

A Comparison of Epidermal Growth Factor Receptor Levels and Other Prognostic Parameters in Non-small Cell Lung Cancer

By Fujino S.   Enokibori T.   Tezuka N.   Asada Y.   Inoue S.   Kato H.   Mori A.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2070-2074

Elsevier

Access to resources Recommend Favorite